Literature DB >> 7978862

Receptors for somatostatin and somatostatin analogues in human breast tumors.

G Prévost1, D Hosford, F Thomas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7978862     DOI: 10.1111/j.1749-6632.1994.tb17264.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Somatostatin receptor subtypes in neuroendocrine tumor cell lines and tumor tissues.

Authors:  S Jonas; M John; J Boese-Landgraf; R Häring; G Prevost; F Thomas; S Rosewicz; E O Riecken; B Wiedenmann; P Neuhaus
Journal:  Langenbecks Arch Chir       Date:  1995

2.  Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors.

Authors:  Rishi K Somvanshi; Ujendra Kumar
Journal:  Pharmaceuticals (Basel)       Date:  2012-04-27

3.  Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.

Authors:  M Bontenbal; J A Foekens; S W Lamberts; F H de Jong; W L van Putten; H J Braun; J T Burghouts; G H van der Linden; J G Klijn
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

4.  Inhibition of tumor promoting signals by activation of SSTR2 and opioid receptors in human breast cancer cells.

Authors:  Geetanjali Kharmate; Padmesh S Rajput; Yu-Chen Lin; Ujendra Kumar
Journal:  Cancer Cell Int       Date:  2013-09-23       Impact factor: 5.722

5.  Alteration of somatostatin receptor 2 expression in canine mammary gland tumor.

Authors:  Kosei Sakai; Tomohiro Yonezawa; Hideyuki Yamawaki; Toshifumi Oyamada
Journal:  J Vet Med Sci       Date:  2015-05-18       Impact factor: 1.267

6.  Colocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cells.

Authors:  Heather L Watt; Ujendra Kumar
Journal:  Cancer Cell Int       Date:  2006-03-06       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.